SGHT
Sight Sciences, Inc.
-0.10 (-1.17%)8.05USD46.9K成交股數443M市值–本益比(近四季)5.3股價營收比+19.6%營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 23.4M+34% | 19.7M+3% | 19.9M-1% | 19.6M-8% | 17.5M-9% | 19.1M-5% | 20.2M-14% | 21.4M+14% | 19.3M | 20.0M | 23.5M | 18.8M |
| 營業成本 | 2.0M | 2.7M | 2.7M | 3.0M | 2.4M | 2.5M | 3.3M | 3.0M | 2.8M | 2.7M | 3.4M | 3.0M |
| 毛利 | 21.4M+42% | 17.0M+3% | 17.2M+2% | 16.6M-10% | 15.1M-8% | 16.6M-4% | 16.9M-16% | 18.3M+16% | 16.5M | 17.3M | 20.1M | 15.8M |
| 毛利率 | 91.4% | 86.2% | 86.4% | 84.8% | 86.2% | 86.8% | 83.9% | 85.8% | 85.5% | 86.6% | 85.6% | 83.8% |
| 研發費用 | 2.5M | 2.5M | 3.4M | 4.4M | 4.4M | 4.3M | 4.7M | 4.3M | 4.6M | 4.2M | 5.2M | 4.7M |
| 銷售管理費用 | 22.8M | 26.8M | 21.8M | 23.9M | 24.5M | 24.2M | 23.4M | 26.7M | 26.6M | 26.5M | 30.1M | 28.7M |
| 營業利益 | −3.9M-72% | −12.4M+4% | −7.9M-30% | −11.7M-8% | −13.9M-6% | −11.9M-11% | −11.2M-26% | −12.7M-28% | −14.7M | −13.4M | −15.2M | −17.6M |
| 營業利益率 | -16.6% | -63.0% | -39.7% | -59.6% | -79.2% | -62.5% | -55.7% | -59.2% | -76.4% | -67.0% | -64.7% | -93.3% |
| 稅後淨利 | −4.4M-69% | −13.0M+10% | −8.2M-26% | −11.9M-3% | −14.2M-13% | −11.8M-9% | −11.1M-25% | −12.3M-28% | −16.3M | −13.0M | −14.8M | −17.1M |
| 淨利率 | -19.0% | -65.9% | -41.0% | -61.0% | -80.8% | -62.1% | -54.9% | -57.7% | -84.4% | -65.1% | -62.9% | -90.7% |
| 稀釋 EPS | -0.08-71% | -0.24+4% | -0.16-27% | -0.23-8% | -0.28-15% | -0.23-15% | -0.22-27% | -0.25-29% | -0.33 | -0.27 | -0.30 | -0.35 |
| 稀釋股數 | 54.5M | 53.9M | 52.4M | 51.8M | 51.3M | 50.1M | 50.3M | 49.9M | 49.5M | 48.7M | 48.5M | 48.4M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 79.8M | 85.0M | 92.4M | 102M | 109M | 120M | 119M | 118M | 127M | 145M | 155M | 167M |
| 應收帳款 | 11.4M | 10.6M | 9.7M | 9.6M | 9.4M | 10.8M | 12.9M | 19.9M | 15.6M | 16.9M | 18.1M | 16.4M |
| 存貨 | 5.7M | 7.0M | 8.0M | 6.2M | 5.8M | 6.3M | 6.1M | 6.8M | 6.9M | 9.2M | 7.9M | 7.1M |
| 總資產 | 105M | 110M | 116M | 122M | 130M | 143M | 144M | 150M | 156M | 177M | 185M | 197M |
| 有息負債 | 30.6M | 36.7M | 40.1M | 39.8M | 39.6M | 39.4M | 34.2M | 33.8M | 33.7M | 33.8M | 33.6M | 33.5M |
| 總負債 | 52.0M | 55.8M | 52.0M | 52.0M | 52.1M | 55.3M | 48.6M | 48.1M | 46.4M | 49.6M | 49.2M | 50.3M |
| 股東權益 | 52.9M | 53.9M | 64.3M | 70.0M | 77.6M | 87.5M | 95.0M | 102M | 109M | 127M | 136M | 146M |
| 負債比 | 49.6% | 50.9% | 44.7% | 42.6% | 40.1% | 38.7% | 33.9% | 32.1% | 29.8% | 28.1% | 26.5% | 25.6% |
| 淨現金(現金 − 有息負債) | 49.1M | 48.2M | 52.3M | 61.7M | 69.2M | 81.0M | 84.4M | 84.4M | 93.6M | 111M | 121M | 134M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −7.0M | – | – | −11.6M+19% | – | – | – | −9.8M | – | – | −17.4M |
| 資本支出 | – | 60K | – | – | 0.00 | – | – | – | 117K | – | – | 126K |
| 自由現金流 | – | −7.1M | – | – | −11.6M+17% | – | – | – | −9.9M | – | – | −17.5M |
| 折舊攤銷 | – | 103K | – | – | 149K | – | – | – | 192K | – | – | 146K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -36.0% | – | – | -66.3% | – | – | – | -51.4% | – | – | -93.0% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 77.4M
| Surgical Glaucoma | 75.7M | 97.9% | -0.2% |
|---|---|---|---|
| Dry Eye | 1.6M | 2.1% | -58.7% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 77.4M | -3.1% | −38.4M | -49.7% | -0.74 | −29.9M |
| FY2024 | 79.9M | -1.5% | −51.5M | -64.5% | -1.03 | −22.7M |
| FY2023 | 81.1M | +13.6% | −55.5M | -68.5% | -1.14 | −48.0M |
| FY2022 | 71.3M | +45.7% | −86.2M | -120.9% | -1.80 | −76.9M |
| FY2021 | 49.0M | +77.1% | −63.0M | -128.6% | -2.36 | −53.4M |
| FY2020 | 27.6M | – | −34.7M | -125.5% | -3.71 | −33.1M |